Agnieszka Anna Markiewicz-Gospodarek

Dr. Agnieszka Anna Markiewicz-Gospodarek


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
RMRenata Markiewicz
Renata Markiewicz
AMAgnieszka Anna Markiewicz-Gospodarek
Agnieszka Anna Markiewicz-Gospodarek
Beata DobrowolskaBeata Dobrowolska
Beata Dobrowolska
This narrative review is aimed at presenting the galvanic skin response (GSR) Biofeedback method and possibilities for its application in persons with mental disorders as a modern form of neurorehabilitation. In the treatment of mental disorders of various backgrounds and courses, attention is focused on methods that would combine pharmacological treatment with therapies improving functioning. Currently, the focus is on neuronal mechanisms which, being physiological markers, offer opportunities for correction of existing deficits. One such indicator is electrodermal activity (EDA), providing information about emotions, cognitive processes, and behavior, and thus, about the function of various brain regions. Measurement of the galvanic skin response (GSR), both skin conductance level (SCL) and skin conductance responses (SCR), is used in diagnostics and treatment of mental disorders, and the training method itself, based on GSR Biofeedback, allows for modulation of the emotional state depending on needs occurring. Summary: It is relatively probable that neurorehabilitation based on GSR-BF is a method worth noticing, which—in the future—can represent an interesting area of rehabilitation supplementing a comprehensive treatment for people with mental disorders.

5 June 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
AGAleksandra Górska
Aleksandra Górska
AMAgnieszka Anna Markiewicz-Gospodarek
Agnieszka Anna Markiewicz-Gospodarek
RMRenata Markiewicz
Renata Markiewicz
ZCZuzanna Chilimoniuk
Zuzanna Chilimoniuk
BBBartosz Borowski
Bartosz Borowski
KCKatarzyna Czarnek
Katarzyna Czarnek
Recent data on the distribution and influence of copper, zinc and cadmium in glial cells are summarized. This review also examines the relationship between those metals and their role in neurodegenerative diseases like Alzheimer disease, multiple sclerosis, Parkinson disease and Amyotrophic lateral sclerosis, which have become a great challenge for today’s physicians. The studies suggest that among glial cells, iron has the highest concentration in oligodendrocytes, copper in astrocytes and zinc in the glia of hippocampus and cortex. Previous studies have shown neurotoxic effects of copper, iron and manganese, while zinc can have a bidirectional effect, i.e., neurotoxic but also neuroprotective effects depending on the dose and disease state. Recent data point to the association of metals with neurodegeneration through their role in the modulation of protein aggregation. Metals can accumulate in the brain with aging and may be associated with age-related diseases.

Verified
Journal Article
Open access
PDF file
AGAleksandra Górska
Aleksandra Górska
AMAgnieszka Anna Markiewicz-Gospodarek
Agnieszka Anna Markiewicz-Gospodarek
MTMateusz Trubalski
Mateusz Trubalski
MŻMarta Żerebiec
Marta Żerebiec
JPJulia Poleszak
Julia Poleszak
RMRenata Markiewicz
Renata Markiewicz
This study examines the impact of zinc, copper, cobalt, iron, and manganese on cancer development, considering their dual roles as potential promoters or inhibitors within tumorigenesis. A comprehensive analysis of existing literature and experimental data is conducted to elucidate the intricate relationship between these trace elements and cancer progression. The findings highlight the multifaceted effects of zinc, copper, cobalt, iron, and manganese on various aspects of cancer development, including cell proliferation, angiogenesis, and metastasis. Understanding the nuanced interactions between these trace elements and cancer could offer crucial insights into tumorigenesis mechanisms and facilitate the identification of novel biomarkers and therapeutic targets for cancer prevention and treatment strategies. This research underscores the importance of considering the roles of essential trace elements in cancer biology and may ultimately contribute to advancements in precision medicine approaches for combating cancer.

12 August 2021 in Neural Plasticity
Verified
Journal Article
Open access
PDF file
RMRenata Markiewicz
Renata Markiewicz
AMAgnieszka Anna Markiewicz-Gospodarek
Agnieszka Anna Markiewicz-Gospodarek
Beata DobrowolskaBeata Dobrowolska
Beata Dobrowolska
BŁBartosz Łoza
Bartosz Łoza
Objectives. The aim of this study was to use neurofeedback (NF) training as the add-on therapy in patients with schizophrenia to improve their clinical, cognitive, and psychosocial condition. The study, thanks to the monitoring of various conditions, quantitative electroencephalogram (QEEG) and brain-derived neurotrophic factor (BDNF), was supposed to give an insight into mechanisms underlying NF training results. Methods. Forty-four male patients with schizophrenia, currently in a stable, incomplete remission, were recruited into two, 3-month rehabilitation programs, with standard rehabilitation as a control group (R) or with add-on NF training (NF). Pre- and posttherapy primary outcomes were compared: clinical (Positive and Negative Syndrome Scale (PANSS)), cognitive (Color Trails Test (CTT), d2 test), psychosocial functioning (General Self-Efficacy Scale (GSES), Beck Cognitive Insight Scale (BCIS), and Acceptance of Illness Scale (AIS)), quantitative electroencephalogram (QEEG), auditory event-related potentials (ERPs), and serum level of BDNF. Results. Both groups R and NF improved significantly in clinical ratings (Positive and Negative Syndrome Scale (PANSS)). In-between analyses unveiled some advantages of add-on NF therapy over standard rehabilitation. GSES scores improved significantly, giving the NF group of patients greater ability to cope with stressful or difficult social demands. Also, the serum-level BDNF increased significantly more in the NF group. Post hoc analyses indicated the possibility of creating a separate PANSS subsyndrome, specifically related to cognitive, psychosocial, and BDNF effects of NF therapy. Conclusions. Neurofeedback can be effectively used as the add-on therapy in schizophrenia rehabilitation programs. The method requires further research regarding its clinical specificity and understanding mechanisms of action.

AMAgnieszka Anna Markiewicz-Gospodarek
Agnieszka Anna Markiewicz-Gospodarek
AGAleksandra Górska
Aleksandra Górska
RMRenata Markiewicz
Renata Markiewicz
ZCZuzanna Chilimoniuk
Zuzanna Chilimoniuk
MCMarcin Czeczelewski
Marcin Czeczelewski
JMJolanta Masiak
Jolanta Masiak
In this review the authors discuss that COVID-19 has already had a direct impact on the physical health of many people and that it appears to have put at risk the mental health of large populations. In this review, we also discuss the relationship between mental disorders and the SARS-CoV-2 infection. We convey the disorders’ risk factors and the more serious mental disorder consequences of COVID-19. People with mental health disorders could be more susceptible to the emotional responses brought on by the COVID-19 epidemic. The COVID-19 pandemic may adversely influence the mental health of patients with already diagnosed mental disorders. For the aim of dealing better with the psychological problems of people afflicted by the COVID-19 pandemic, new psychological procedures are required.

Verified
Journal Article
Open access
PDF file
MTMateusz Trubalski
Mateusz Trubalski
AMAgnieszka Anna Markiewicz-Gospodarek
Agnieszka Anna Markiewicz-Gospodarek
MŻMarta Żerebiec
Marta Żerebiec
JPJulia Poleszak
Julia Poleszak
MSMiłosz Szczotka
Miłosz Szczotka
SSSylwia Edyta Szymańczyk
Sylwia Edyta Szymańczyk
Schizophrenia is a complex neuropsychiatric disorder characterized by a diverse range of symptoms, including positive, negative symptoms such as alogia, anhedonia, avolition, and affective flattening, cognitive symptoms, and emotional symptoms as a separate domain. Emerging evidence suggests that oxidative stress and neuroinflammation play crucial roles in the etiopathogenesis of schizophrenia. The aim of this review is the interplay between oxidative stress—defined as an imbalance between reactive oxygen species (ROS) production and antioxidant defenses—and neuroinflammatory processes within the central nervous system. Studies indicate that elevated levels of oxidative markers and pro-inflammatory cytokines are commonly observed in individuals with schizophrenia, pointing to a potential pathophysiological link. The dysregulation of redox homeostasis may exacerbate neuroinflammatory responses, contributing to neuronal damage and the subsequent manifestation of psychiatric symptoms. Furthermore, genetic and environmental factors may interact with these biological processes, influencing individual susceptibility to schizophrenia. Understanding the mechanisms by which oxidative stress and neuroinflammation contribute to the development and progression of schizophrenia could pave the way for novel therapeutic strategies aimed at mitigating these pathological processes and improving patient outcomes.